Drug Type Biological products |
Synonyms |
Target |
Action modulators |
Mechanism TRBV9 gene modulators |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Axial Spondyloarthritis | Preclinical | United States | 26 Mar 2025 |